第二届全球医药峰会——2012 CRO外包合作发展论坛/2nd Global Pharmaceutical Summit- CRO Forum

会议背景 Conference Background:

医药行业研发周期高成本、高风险，CRO (Contract Research Organization）医药合同研发外包服务应运而生。CRO承担了全球1/3以上新药开发的组织工作，全球医药外包市场以每年20%～25%的速度增长。中国CRO医药合同外包服务已形成相当的市场规模，但仍然处于启动期。
       
第二届全球医药峰会——2012 CRO外包合作发展论坛，将于2012年5月在上海召开。在行业规范体系日趋完善并逐步与国际接轨的背景下，CRO企业如何吸引并提升专业技术人才和管理人才，有效利用资源优势参与国际竞争。会议并将促进CRO联盟的形成，深入CRO之间以及CRO与制药企业间的交流与合作。

Conference Background:

The high-cost and the high risk during the Pharmaceutical R&D process necessitate the development of a Contract Research Organization, i.e. CRO. Pharmaceutical CRO has taken over one-third of the R&D of new drugs all over the world and its market size is growing at an annual rate of 20% to 25%. Although China’s CRO industry had begun to take shape, it is still at the beginning stage.
Under the background of the CRO industry’s system and standard improvement, 2nd Global Pharmaceutical Summit - CRO Forum will be held by Ringier on May 17-18, 2012 in Shanghai.
- How to attract and enhance professional technicians and management personnel?
- How to use the resources effectively and participate into the international competition?
The conference will promote the formation of CRO Alliances, as well as the exchange and cooperation between CRO and pharmaceutical companies.

嘉宾收益 Benefits from the conference:

触摸全球医药行业CRO最新发展动向；
Understanding the current industrial development trend in Asia and the rest of the world;
优化企业在中国和其他区域的内部及外部的资源整合；
Optimizing the internal resources and outsourcing partnership within and outside China
 
获得在中国迅速发展的临床前领域的契机；
Finding opportunities in China’s rapidly developing preclinical and clinical sectors;
探讨如何发挥中国在成本，人力和基础设施等方面的优势；
Exploring China’s advantages in cost, talent pool and infrastructure support;
发展新药探索模式从而带动药品研发的生产力；
Developing new drug discovery models to drive R&D productivity;
培育研究成果在中国市场的商品化并实现持续发展和创新；
Cultivating a sustainable pipeline of research commercialization and spin-offs in China;
学习国际CRO巨头运营管理的成功经验,提高自身行业竞争力；
Learning successful experiment from the best practices by top CRO companies;
拓展同来自世界各国200多家顶尖CRO企业代表的网络合作关系
Networking with key industry professionals from more than 200 international leading CROs

拟定议程 Proposed Agenda:

政策法规与市场趋势 Policy & Regulation & Market Development Trend
主题演讲：现状 - 中国医药CRO发展现状及全球视角下中国CRO行业的优劣势比较分析
Keynote: Situation - Current situation and development of China CRO; Compare industrial advantage and  disadvantage under global perspective
主题演讲：政策 - 中国“十二五”规划下推动CRO行业发展的相关鼓励及刺激扶持性政策解读
Keynote: Policy - Analysis of incentive policies for industrial development strategy during the 12th five-year plan
主题演讲：法规 - CRO行业发展前景及行业运营管理体系的规范与国际化进程
Keynote: Regulation - Prospects for CRO development, standard and international processing of management system
主题演讲：趋势 - 中国及全球医药CRO行业趋势走向及业务格局的发展变化预测
Keynote: Trends- China and global CRO industrial trends, forecast business circumstances development
运营管理与业务拓展  Management & Business Development
国际药物研发热点与中国新药研发创新机遇
International Pharmaceutical R&D hot topic and opportunities of China Pharmaceutical R&D
如何切实了解客户需求并建立完善的满足适应客户需求的科学服务体系
Understanding and building perfect scientific service system  to meet clients needs
CRO企业的资质认证及严格的质量管理体系的建立
Building industrial strict quality management system and qualification
构建高效的项目管理体系及国际化的运作模式，发展成熟并具备国际竞争力的CRO公司
Building efficient project management system and international operation mode;
Developing CRO companies with international competitiveness
新药研发临床前研究 Pharmaceutical Preclinical R&D
§先导化合物的发现、优化及活性筛选
Discovery, optimization and activity screening for leading compound
§药物作用靶点的发现与验证：新药药物靶标的生物化学性质研究
Target identification & validation: Pharmaceutical Biochemistry R&D
§抗癌症药物生物标记物的研究进展
 Anti-cancer drugs’ biological markers R&D
§生物技术药物研发中试放大与分离纯化技术
Biotechnology drug R & D scale-up and separation and purification technology
§生物技术药物研究开发中质量标准制定与质量控制技术
Quality standards and control for biotechnology drug R&D
§药物临床前研发过程中的项目管理：研究设计、 试验设施及数据分析等
Project management during pharmaceutical preclinical R&D: Study design, facilities and data interpretation
§新药研发中的药物药理毒理研究的技术要求
Technical requirements of pharmacology and toxicology studies in pharmaceutical R&D
§新药研发安全性评价中毒理病理学检验存在的问题
The problems of toxicological pathology test and safety evaluation during the pharmaceutical R&D
§新药临床前毒理安全性评价的规范化管理；毒理病理学报告的国际GLP规范
Standardized management of pharmaceutical preclinical toxicological safety evaluation, GLP standard
§动物试验模型：毒理学与效果测试
Animal test model: toxicology and efficacy testing

演讲嘉宾 Speakers’ Info:
国内外医药行业相关政府管理机构领导；
   Officers from pharmaceutical industry relevant policy and regulation agencies;
行业协会/院校科研机构专家学者；
   Academics from social associations, universities and institutes;
顶级CRO公司决策者及部门负责人 （研发中心，政策法规，安全检测与质量管理等部门）；
  Decision makers and department directors from international leading CROs;
跨国制药公司及生命科学、生物技术公司高管；
  Senior managers from international pharmaceutical companies and biotechnology companies;
法律/认证注册方面资深咨询师等
  Senior consultants with strong pharmaceutical background

涵盖学科领域如下 Subjects covered are as follows:
肿瘤、心血管病、药代动力学等新药临床研究技术；生物制剂、疫苗的研发；抗体组药物及抗体公共服务研究；SOP标准操作程序；GLP管理规范；CMO服务平台；动物试验；医药经济研究；CRO投资风险评估等
Cancer, cardiovascular diseases, pharmacokinetics, new technologies of clinical research; Biopharmaceuticals, vaccine R&D; Antibody group drug and study of antibody public service; SOP research; GLP; CMO service platform; Animal testing; Pharmaceutical economic research; Data management services; CRO investment risk assessment etc.

赞助机会与收益 Sponsorship Opportunity:

跨国制药公司
Pharmaceutical companies
生物技术公司
Biotech
抗体平台技术提供商
Antibody platform technology provider
蛋白工艺提供商
Protein technology providers
仪器设备供应商
Laboratory equipment suppliers
医药研发专业试剂供应商等
Professional reagent suppliers for pharmaceutical R&D

全方位的媒体市场高效宣传；
Access to a full range of high-publicity media market;

会议中的宝贵演讲机会；
Valuable opportunity to deliver speeches at the meeting;

面向用户企业零距离,一对一展示最新产品技术等
Opportunity to showcase the user-oriented latest products or new research achievements etc.